Replies to post #1177 on Chelsea Therapeutics Intl Ltd fka CHIP

[WARRIOR6267]

I sold day late dollar short 7.8% profit is profit i guess...

[chmcnfunds]

Just bought in. Believe that AF is positive about Chelsea. It was an SA article:

Quote:
______________________________________
Andrew I. emails:

Hello Adam! Hope you have a Happy New Year! I was wondering what your thoughts are on Chelsea Therapeutics (CHTP_) getting Northera approved? I saw a long article by Nick Zheng on Seeking Alpha that broke things down in detail and was not favorable. I wonder if you had seen that article and what your thoughts were?

Zheng says the Northera FDA advisory panel on Jan. 14 has a 60% chance of being negative, by which I assume he's predicting the experts on the panel will advise FDA not to approve the drug without additional clinical data.

I'm taking the other side of the bet. I laid out my reasons to be bullish about Chelsea's chances in November. I will say Zheng and I probably agree on Northera almost as much as we disagree. Chelsea is in for a tough fight at the Jan. 14 panel because the Northera data are far from confidence inspiring, as I explained in November.

No one said Chelsea is going to have an easy time at the Northera FDA panel. Like in February 2012, the company will need to present its data well and be prepared to answer some tough questions. My confidence in a positive panel vote lies in the totality of the Northera data which makes a risk-benefit argument.
________________________________
http://www.thestreet.com/story/12201246/2/biotech-stock-mailbag-inovio-chelsea-exelixis-ariad-immunocellular.html

CHTP